alanine and epoxyfarnesyl diazoacetate

alanine has been researched along with epoxyfarnesyl diazoacetate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aralaguppe, SG; Neogi, U; Njenda, DT; Rao, R; Sarafianos, SG; Singh, K; Sönnerborg, A	1
Coelho, LE; Grinsztejn, B; Landovitz, RJ; Torres, TS; Veloso, VG	1

Reviews

1 review(s) available for alanine and epoxyfarnesyl diazoacetate

Article	Year
Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline. The lancet. HIV, 2019, Volume: 6, Issue:11 Topics: Adenine; Administration, Cutaneous; Administration, Oral; Alanine; Contraceptive Devices, Female; Delayed-Action Preparations; Deoxyadenosines; Emtricitabine; Female; HIV Infections; Humans; Incidence; Male; Medication Adherence; Pre-Exposure Prophylaxis; Tenofovir	2019

Other Studies

1 other study(ies) available for alanine and epoxyfarnesyl diazoacetate

Article	Year
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes. The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10 Topics: Adenine; Alanine; Anti-Retroviral Agents; Deoxyadenosines; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Recombination, Genetic; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure	2018

Article

Year

Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes.

The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10

Topics: Adenine; Alanine; Anti-Retroviral Agents; Deoxyadenosines; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Recombination, Genetic; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure

2018